 | • レポートコード：MRC2304D102 • 出版社/出版日：Transparency Market Research / 2023年1月12日 • レポート形態：英文、PDF、195ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、大容量ネブライザーの世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別（超音波ネブライザー、ジェットネブライザー、メッシュネブライザー）分析、容量別（200-490ml、500-800ml、>800ml）分析、用途別（COPD、喘息、嚢胞性線維症、その他）分析、エンドユーザー別（病院、クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを収録しています。また、Teleflex Incorporated、PARI GmbH、Tri-Anim Health Services, Inc.、Vyaire Medical、Sarnova, Inc.、Winnomed、GaleMed Corporation、Vadi Medical Technology Co., Ltd.などの企業情報を掲載しています。 ・序論 ・仮定＆調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の大容量ネブライザー市場規模：製品種類別 - 超音波ネブライザーの市場規模 - ジェットネブライザーの市場規模 - メッシュネブライザーの市場規模 ・世界の大容量ネブライザー市場規模：容量別 - 200-490mlのネブライザー市場規模 - 500-800mlのネブライザー市場規模 - >800mlのネブライザー市場規模 ・世界の大容量ネブライザー市場規模：用途別 - COPDにおける市場規模 - 喘息における市場規模 - 嚢胞性線維症における市場規模 - その他用途における市場規模 ・世界の大容量ネブライザー市場規模：エンドユーザー別 - 病院における市場規模 - クリニックにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の大容量ネブライザー市場規模：地域別 - 北米の大容量ネブライザー市場規模 - ヨーロッパの大容量ネブライザー市場規模 - アジア太平洋の大容量ネブライザー市場規模 - 中南米のアルミニウムスラグ市場規模 - 中東・アフリカのアルミニウムスラグ市場規模 ・競争状況 |
Large Volume Nebulizers Market – Scope of Report
TMR’s report on the global large volume nebulizers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global large volume nebulizers market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global large volume nebulizers market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the large volume nebulizers market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global large volume nebulizers market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global large volume nebulizers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global large volume nebulizers market.
The report delves into the competitive landscape of the global large volume nebulizers market. Key players operating in the global large volume nebulizers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global large volume nebulizers market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market large volume nebulizers.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Large Volume Nebulizers Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Large Volume Nebulizers Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projection (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. COVID-19 Impact Analysis
6. Global Large Volume Nebulizers Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Ultrasonic Nebulizers
6.3.2. Jet Nebulizers
6.3.3. Mesh Nebulizers
6.4. Market Attractiveness Analysis, by Product Type
7. Global Large Volume Nebulizers Market Analysis and Forecast, by Volume
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Volume, 2017–2031
7.3.1. 200-490 ml
7.3.2. 500-800 ml
7.3.3. >800 ml
7.4. Market Attractiveness Analysis, by Volume
8. Global Large Volume Nebulizers Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Chronic Obstructive Pulmonary Disease (COPD)
8.3.2. Asthma
8.3.3. Cystic Fibrosis
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Large Volume Nebulizers Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Large Volume Nebulizers Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Large Volume Nebulizers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Ultrasonic Nebulizers
11.2.2. Jet Nebulizers
11.2.3. Mesh Nebulizers
11.3. Market Value Forecast, by Volume, 2017–2031
11.3.1. 200-490 ml
11.3.2. 500-800 ml
11.3.3. >800 ml
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Chronic Obstructive Pulmonary Disease (COPD)
11.4.2. Asthma
11.4.3. Cystic Fibrosis
11.4.4. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Volume
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Large Volume Nebulizers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Ultrasonic Nebulizers
12.2.2. Jet Nebulizers
12.2.3. Mesh Nebulizers
12.3. Market Value Forecast, by Volume, 2017–2031
12.3.1. 200-490 ml
12.3.2. 500-800 ml
12.3.3. >800 ml
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Chronic Obstructive Pulmonary Disease (COPD)
12.4.2. Asthma
12.4.3. Cystic Fibrosis
12.4.4. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Volume
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Large Volume Nebulizers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Ultrasonic Nebulizers
13.2.2. Jet Nebulizers
13.2.3. Mesh Nebulizers
13.3. Market Value Forecast, by Volume, 2017–2031
13.3.1. 200-490 ml
13.3.2. 500-800 ml
13.3.3. >800 ml
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Chronic Obstructive Pulmonary Disease (COPD)
13.4.2. Asthma
13.4.3. Cystic Fibrosis
13.4.4. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Volume
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Large Volume Nebulizers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Ultrasonic Nebulizers
14.2.2. Jet Nebulizers
14.2.3. Mesh Nebulizers
14.3. Market Value Forecast, by Volume, 2017–2031
14.3.1. 200-490 ml
14.3.2. 500-800 ml
14.3.3. >800 ml
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Chronic Obstructive Pulmonary Disease (COPD)
14.4.2. Asthma
14.4.3. Cystic Fibrosis
14.4.4. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Volume
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Large Volume Nebulizers Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Ultrasonic Nebulizers
15.2.2. Jet Nebulizers
15.2.3. Mesh Nebulizers
15.3. Market Value Forecast, by Volume, 2017–2031
15.3.1. 200-490 ml
15.3.2. 500-800 ml
15.3.3. >800 ml
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Chronic Obstructive Pulmonary Disease (COPD)
15.4.2. Asthma
15.4.3. Cystic Fibrosis
15.4.4. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Volume
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2021)
16.3. Company Profiles
16.3.1. Teleflex Incorporated
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. Tri-Anim Health Services, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. Vyaire Medical
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. Sarnova, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Winnomed
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. GaleMed Corporation
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Vadi Medical Technology Co., Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. PARI GmbH
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview